• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why AMC Entertainment Holdings Shares Are Trading Higher By 41%; Here Are 20 Stocks Moving Premarket

    7/24/23 8:16:44 AM ET
    $AKU
    $AMC
    $APPH
    $BGLC
    Medical Specialities
    Health Care
    Movies/Entertainment
    Consumer Discretionary
    Get the next $AKU alert in real time by email

    Gainers

    • ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) rose 45% to $0.2890 in pre-market trading after falling over 8% on Friday.
    • AMC Entertainment Holdings, Inc. (NYSE:AMC) shares surged 41% to $6.19 in pre-market trading after a Delaware judge denied the company from converting its AMC preferred equity units into common stock.
    • POSCO Holdings Inc. (NYSE:PKX) shares gained 19.2% to $125.98 in pre-market trading following strong quarterly earnings.
    • Akumin Inc. (NASDAQ:AKU) gained 13.5% to $0.2099 in pre-market trading. Akumin, last month, named Krishna Kumar as President and Chief Operating Officer.
    • Koss Corporation (NASDAQ:KOSS) shares gained 13.3% to $4.09 in pre-market trading.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) shares rose 8.1% to $0.1088 in pre-market trading. The FDA recently granted breakthrough Device designation for the company's Candida auris direct-from-blood molecular diagnostic test. test.
    • Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) gained 7.6% to $2.68 in pre-market trading after jumping over 18% on Friday.
    • BioNexus Gene Lab Corp. (NASDAQ:BGLC) shares rose 6.4% to $6.33 in pre-market trading after gaining 22% on Friday.
    • Tupperware Brands Corporation (NYSE:TUP) rose 5.6% to $0.95 in pre-market trading after jumping over 35% on Friday.
    • DURECT Corporation (NASDAQ:DRRX) shares climbed 5.2% to $3.21 in pre-market trading after declining 7% on Friday. DURECT recently announced a $15 million registered direct offering priced at-the-market under Nasdaq rules.

    Losers

    • Contango Ore, Inc. (NYSE:CTGO) fell 24.3% to $20.06 in pre-market trading after the company reported an underwritten public offering of common stock.
    • AppHarvest, Inc. (NASDAQ:APPH) shares fell 22.4% to $0.2598 in pre-market trading. AppHarvest announced Chapter 11 filing to support a financial and operational transition.
    • ViewRay, Inc. (NASDAQ:VRAY) fell 20.9% to $0.0467 in pre-market trading after the company reported commencement of Nasdaq delisting proceedings. The company’s common stock is expected to begin trading on the over-the counter markets.
    • E-Home Household Service Holdings Limited (NASDAQ:EJH) fell 20.7% to $0.0999 in pre-market trading.
    • 22nd Century Group, Inc. (NASDAQ:XXII) fell 15.6% to $4.09 in pre-market trading after jumping 31% on Friday. 22nd Century Group recently announced it regained compliance with Nasdaq listing requirements.
    • PSQ Holdings, Inc. (NYSE:PSQH) fell 11.6% to $18.66 in pre-market trading after declining 29% on Friday. Trading of PublicSq.'s shares of Class A common stock commenced Thursday following the successful completion of its previously announced business combination with Colombier Acquisition Corp.
    • Hitek Global Inc. (NASDAQ:HKIT) fell 10.4% to $5.93 in pre-market after gaining over 13% on Friday.
    • Camber Energy, Inc. (NYSE:CEI) shares fell 9.8% to $1.10 in pre-market trading. Camber Energy shares gained 53% on Friday after the company and Viking Energy announced shareholder approval of the merger.
    • AMC Entertainment Holdings, Inc. (NYSE:APE) fell 7.2% to $1.67 in pre-market trading after Delaware judge denied the company from converting it's AMC preferred equity units into common stock.
    • Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) shares fell 6.8% to $0.2060 in pre-market trading. MEI Pharma failed to secure stockholder approval for the merger deal with Infinity Pharmaceuticals.

     

    Now Read This: Investor Sentiment Improves After Dow Gains For 10th Straight Session

    Get the next $AKU alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKU
    $AMC
    $APPH
    $BGLC

    CompanyDatePrice TargetRatingAnalyst
    Contango Silver & Gold Inc.
    $CTGO
    3/26/2026$32.00Buy
    Canaccord Genuity
    AMC Entertainment Holdings Inc.
    $AMC
    7/11/2025$4.00Neutral → Outperform
    Wedbush
    POSCO HOLDINGS INC.
    $PKX
    7/7/2025Equal-Weight → Overweight
    Morgan Stanley
    AMC Entertainment Holdings Inc.
    $AMC
    5/16/2025$3.00Neutral
    B. Riley Securities
    Dragonfly Energy Holdings Corp.
    $DFLI
    3/25/2025$9.00 → $1.50Buy → Neutral
    Alliance Global Partners
    AMC Entertainment Holdings Inc.
    $AMC
    2/4/2025$4.00 → $3.25Sell → Neutral
    ROTH MKM
    PSQ Holdings Inc.
    $PSQH
    1/15/2025$8.00Buy
    Maxim Group
    Dragonfly Energy Holdings Corp.
    $DFLI
    5/23/2024$1.75Buy
    Alliance Global Partners
    More analyst ratings

    $AKU
    $AMC
    $APPH
    $BGLC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Wenshan Xie

    4 - E-Home Household Service Holdings Ltd (0001769768) (Issuer)

    4/3/26 10:56:58 AM ET
    $EJH
    Other Consumer Services
    Consumer Discretionary

    SEC Form 3 filed by new insider Ye Yijing

    3 - E-Home Household Service Holdings Ltd (0001769768) (Issuer)

    4/1/26 5:14:03 PM ET
    $EJH
    Other Consumer Services
    Consumer Discretionary

    SEC Form 4 filed by Clark Michael Aaron

    4 - Contango ORE, Inc. (0001502377) (Issuer)

    3/20/26 4:46:47 PM ET
    $CTGO
    Precious Metals
    Basic Materials

    $AKU
    $AMC
    $APPH
    $BGLC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Contango ORE with a new price target

    Canaccord Genuity initiated coverage of Contango ORE with a rating of Buy and set a new price target of $32.00

    3/26/26 9:38:05 AM ET
    $CTGO
    Precious Metals
    Basic Materials

    AMC Entertainment upgraded by Wedbush with a new price target

    Wedbush upgraded AMC Entertainment from Neutral to Outperform and set a new price target of $4.00

    7/11/25 7:55:26 AM ET
    $AMC
    Movies/Entertainment
    Consumer Discretionary

    POSCO upgraded by Morgan Stanley

    Morgan Stanley upgraded POSCO from Equal-Weight to Overweight

    7/7/25 8:11:24 AM ET
    $PKX
    Steel/Iron Ore
    Industrials

    $AKU
    $AMC
    $APPH
    $BGLC
    SEC Filings

    View All

    AMC Entertainment Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - AMC ENTERTAINMENT HOLDINGS, INC. (0001411579) (Filer)

    4/1/26 4:55:42 PM ET
    $AMC
    Movies/Entertainment
    Consumer Discretionary

    SEC Form 6-K filed by Hitek Global Inc.

    6-K - HiTek Global Inc. (0001742341) (Filer)

    4/1/26 8:45:01 AM ET
    $HKIT
    Computer Software: Prepackaged Software
    Technology

    SEC Form 6-K filed by Hitek Global Inc.

    6-K - HiTek Global Inc. (0001742341) (Filer)

    3/31/26 9:18:03 PM ET
    $HKIT
    Computer Software: Prepackaged Software
    Technology

    $AKU
    $AMC
    $APPH
    $BGLC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for POSIMIR

    Submission status for DURECT CORP's drug POSIMIR (ORIG-1) with active ingredient BUPIVACAINE has changed to 'Approval' on 02/01/2021. Application Category: NDA, Application Number: 204803, Application Classification: Type 3 - New Dosage Form

    2/2/21 7:24:30 AM ET
    $DRRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKU
    $AMC
    $APPH
    $BGLC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hitek Announces 50-for-1 Share Consolidation

    XIAMEN, China, April 1, 2026 /PRNewswire/ -- HiTek Global Inc. (NASDAQ:HKIT) (the "Company"), an information technology consulting and solutions provider, announced today that it will effect a 50-for-1 share consolidation of its Class A ordinary shares, effective April 6, 2026 (the "Share Consolidation"), in order to meet the minimum bid price requirement for continued listing on the Nasdaq Capital Market. Beginning with the opening of trading on April 6, 2026, the Company's Class A ordinary shares will begin trading on the Nasdaq Capital Market on a split-adjusted basis under the same trading symbol, "HKIT," and a new CUSIP number, G45139113. On November 24, 2025, at the 2025 Annual General

    4/1/26 8:40:00 AM ET
    $HKIT
    Computer Software: Prepackaged Software
    Technology

    ZyVersa Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update

    ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal diseases with a total accessible market >$100 billion.Inflammasome ASC Inhibitor IC 100 is a next generation drug designed for unparalleled control of disease-causing inflammation by (1) inhibiting multiple inflammasomes activated in numerous diseases, not just NLRP3, and (2) attenuating spread and perpetuation of inflammation by uniquely inhibiting ASC specks. Lead indication: Cardiometabolic conditions associated with obesityValue driving milestones: File IND Q4-2026; Phase 1 SAD read-out Q1-2027 Cholesterol Efflux Mediator VAR 200 is expected to be a disease-modifying renal drug by targeting unaddress

    3/31/26 5:05:00 PM ET
    $ZVSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Univest Securities, LLC Announces Closing of $3 Million Registered Direct Offering for its Client Hitek Global Inc. (NASDAQ: HKIT)

    New York, March 31, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the "Offering") of approximately $3 million for its client Hitek Global Inc. (NASDAQ:HKIT) (the "Company"), a China-based information technology consulting and solutions service provider. Under the terms of the securities purchase agreement, the Company has agreed to sell to certain institutional investors an aggregate of 100,000,000 of the Company's Class A ordinary shares (the "Shares") (or pre-funded warrants in lieu thereof) at a

    3/31/26 5:00:00 PM ET
    $HKIT
    Computer Software: Prepackaged Software
    Technology

    $AKU
    $AMC
    $APPH
    $BGLC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lillie Lenore bought $12,400 worth of shares (2,500 units at $4.96) (SEC Form 4)

    4 - KOSS CORP (0000056701) (Issuer)

    12/4/25 4:30:03 PM ET
    $KOSS
    Consumer Electronics/Appliances
    Consumer Staples

    Chief Executive Officer Seifert Michael Stephen bought $10,000 worth of shares (7,143 units at $1.40), increasing direct ownership by 6% to 133,955 units (SEC Form 4)

    4 - PSQ Holdings, Inc. (0001847064) (Issuer)

    12/1/25 7:10:54 PM ET
    $PSQH
    Advertising
    Consumer Discretionary

    Chief People Officer Hebert Michael Robert sold $36,130 worth of shares (23,310 units at $1.55) and bought $15,102 worth of shares (9,400 units at $1.61), decreasing direct ownership by 4% to 252,876 units (SEC Form 4)

    4 - PSQ Holdings, Inc. (0001847064) (Issuer)

    11/17/25 8:08:29 PM ET
    $PSQH
    Advertising
    Consumer Discretionary

    $AKU
    $AMC
    $APPH
    $BGLC
    Leadership Updates

    Live Leadership Updates

    View All

    BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman

    Enhanced board oversight aligns subsidiary with disciplined capital allocation and strategic evaluation framework KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BioNexus" or the "Company"), today announced the completion of a governance restructuring of its wholly owned subsidiary, Chemrex Corporation Sdn. Bhd. ("Chemrex"). As part of this restructuring, Chemrex's board has been streamlined to two directors: Matthew L. Barsing, ChairmanAngeline Chong, Chief Financial Officer of BioNexus, Director New officers are expected to be appointed in the coming months. Chemrex remains a wholly owned private subsidiary of BioNexus and operates un

    2/23/26 8:30:00 AM ET
    $BGLC
    Medical Specialities
    Health Care

    PublicSquare Appoints Dusty Wunderlich as Chief Executive Officer

    New Leadership Reinforces Progress Toward Fintech Focus PSQ Holdings, Inc. (NYSE:PSQH) ("PublicSquare" or the "Company"), today announced that Dusty Wunderlich has been appointed CEO, effective immediately, as the Company continues its transition to core fintech businesses, including credit and payments. Mr Wunderlich was recently appointed Chairman of the Board of PublicSquare and will remain in that role. As part of this transition, Michael Seifert has stepped down as Chief Executive Officer and resigned from the Company's Board of Directors, effective January 27, 2026. Mr. Wunderlich was CEO of Credova until PublicSquare acquired the company in March 2024. Given his fintech experienc

    1/29/26 7:30:00 AM ET
    $PSQH
    Advertising
    Consumer Discretionary

    LAIKA Partners With Fathom Entertainment for Domestic Distribution and FilmNation Entertainment for International Sales on Wildwood

    Confirms October 23, 2026 U.S. Release Date LAIKA, the studio behind Coraline and ParaNorman, announced today that it has partnered with Fathom Entertainment for U.S. theatrical distribution and FilmNation Entertainment for international sales on its upcoming stop-motion feature film Wildwood. The film will open in theaters nationwide on October 23, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120938376/en/LAIKA Names Fathom Entertainment as US Distributor and FilmNation Entertainment for International Sales for "Wildwood" coming October 23, 2026 The announcement reflects a new phase for LAIKA, as the studio expands

    1/20/26 11:15:00 AM ET
    $AMC
    $CNK
    Movies/Entertainment
    Consumer Discretionary

    $AKU
    $AMC
    $APPH
    $BGLC
    Financials

    Live finance-specific insights

    View All

    ZyVersa Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update

    ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal diseases with a total accessible market >$100 billion.Inflammasome ASC Inhibitor IC 100 is a next generation drug designed for unparalleled control of disease-causing inflammation by (1) inhibiting multiple inflammasomes activated in numerous diseases, not just NLRP3, and (2) attenuating spread and perpetuation of inflammation by uniquely inhibiting ASC specks. Lead indication: Cardiometabolic conditions associated with obesityValue driving milestones: File IND Q4-2026; Phase 1 SAD read-out Q1-2027 Cholesterol Efflux Mediator VAR 200 is expected to be a disease-modifying renal drug by targeting unaddress

    3/31/26 5:05:00 PM ET
    $ZVSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Contango Completes Merger with Dolly Varden

    FAIRBANKS, Alaska and VANCOUVER, BC, March 26, 2026 /PRNewswire/ - Contango Silver & Gold Inc. ("Contango" or the "Company") (NYSE:CTGO) and Dolly Varden Silver Corporation ("Dolly Varden") are pleased to announce they have completed their previously announced merger (the "Arrangement"), following receipt of all required shareholder and court approvals. An application has been submitted to the Toronto Stock Exchange to list the Contango Shares (as defined below) and it is expected that the Contango Shares will be listed shortly, subject to satisfaction of applicable listing requirements and approval of the Toronto Stock Exchange.

    3/26/26 8:00:00 AM ET
    $CTGO
    Precious Metals
    Basic Materials

    22nd Century Group Reports Fourth Quarter and Full Year 2025 Financial Results

    VLN® Commercial Expansion Drives Continued Shift Toward Higher Margin Proprietary Branded Products Expanding VLN® Store Counts and State Authorizations Increase Availability of Smoking Harm Reduction Products MOCKSVILLE, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company focused on reducing the harms of smoking through nicotine reduction, today announced results for the fourth quarter and fiscal year-ended December 31, 2025, and provided an update on recent business highlights. The Company's proprietary low nicotine technology is designed to serve adult smokers who want to change their smoking habits by significantly reduci

    3/26/26 6:00:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $AKU
    $AMC
    $APPH
    $BGLC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by PSQ Holdings Inc.

    SC 13G - PSQ Holdings, Inc. (0001847064) (Subject)

    12/12/24 11:50:43 AM ET
    $PSQH
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13D/A filed by Dragonfly Energy Holdings Corp.

    SC 13D/A - Dragonfly Energy Holdings Corp. (0001847986) (Subject)

    11/21/24 6:10:38 PM ET
    $DFLI
    Industrial Machinery/Components
    Miscellaneous